These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 6982650

  • 1. [Evaluation of circulating T-lymphocytes in epithelial tumors of the ovary and during chemotherapy].
    Bolis PF, Franchi M, Guaschino S, Maccario R.
    Ann Ostet Ginecol Med Perinat; 1982; 103(3):202-5. PubMed ID: 6982650
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical significance of the measurement of cellular immune status in patients with ovarian malignancies].
    Ma D, Gu MJ.
    Zhonghua Fu Chan Ke Za Zhi; 1988 Mar; 23(2):99-101, 128. PubMed ID: 3263914
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Factors influencing ovarian cancer survival after chemotherapy.
    Webb MJ, Malkasian GD, Jorgensen EO.
    Obstet Gynecol; 1974 Oct; 44(4):564-70. PubMed ID: 4413425
    [No Abstract] [Full Text] [Related]

  • 8. [Evaluation of rosette E in patients with endometrial carcinoma (longitudinal study of 43 cases)].
    Bolis PF, Guaschino S, Franchi M, Maccario R.
    Ann Ostet Ginecol Med Perinat; 1982 Oct; 103(2):148-52. PubMed ID: 6981371
    [No Abstract] [Full Text] [Related]

  • 9. Immune function in patients with ovarian carcinoma treated with irradiation or with cytostatics.
    Toivanen A, Grönroos M, Lassila O, Nordman E.
    Acta Obstet Gynecol Scand; 1984 Oct; 63(2):153-8. PubMed ID: 6375243
    [Abstract] [Full Text] [Related]

  • 10. Preliminary studies on the effect of Ukrain (Tris(2-([5bS-(5ba,6b,12ba)]- 5b,6,7,12b,13,14-hexahydro-13-methyl[1,3] benzodioxolo[5,6-v]-1-3- dioxolo[4,5-i]phenanthridinium-6-ol]-Ethaneaminyl)Phosphinesulfide.6HCl ) on the immunological response in patients with malignant tumours.
    Danilos J, Zbroja-Sontag W, Baran E, Kurylcio L, Kondratowicz L, Jusiak L.
    Drugs Exp Clin Res; 1992 Oct; 18 Suppl():55-62. PubMed ID: 1305046
    [Abstract] [Full Text] [Related]

  • 11. Expression of p53 in epithelial carcinoma of the ovary after chemotherapy.
    White CD, Roberts JA.
    J Reprod Med; 1999 Oct; 44(10):837-41. PubMed ID: 10554742
    [Abstract] [Full Text] [Related]

  • 12. Phase II trial of spirogermanium in advanced epithelial carcinoma of the ovary.
    Weiselberg L, Budman DR, Schulman P, Vinciguerra V, Degnan TJ, Pasmantier M.
    Cancer Treat Rep; 1982 Aug; 66(8):1675-6. PubMed ID: 7201885
    [No Abstract] [Full Text] [Related]

  • 13. [T and B lymphocytes in laryngeal carcinoma].
    Zezula J, Rejtnar A, Sůva P.
    Cesk Otolaryngol; 1981 Apr; 30(2):70-4. PubMed ID: 6972271
    [No Abstract] [Full Text] [Related]

  • 14. [Intraperitoneal chemotherapy in ovarian carcinoma. Life prolonging in selected patients].
    Ottevanger PB.
    Ned Tijdschr Geneeskd; 2009 Mar 14; 153(11):503-7. PubMed ID: 19402326
    [No Abstract] [Full Text] [Related]

  • 15. E-rosette forming lymphocytes in carcinoma of uterine cervix patients before and after treatment.
    Singh RP, Shukla M, Singh VP, Udupa KN.
    J Assoc Physicians India; 1987 Mar 14; 35(3):211-2. PubMed ID: 3497155
    [No Abstract] [Full Text] [Related]

  • 16. Optimism, distress, health-related quality of life, and change in cancer antigen 125 among patients with ovarian cancer undergoing chemotherapy.
    de Moor JS, de Moor CA, Basen-Engquist K, Kudelka A, Bevers MW, Cohen L.
    Psychosom Med; 2006 Mar 14; 68(4):555-62. PubMed ID: 16868264
    [Abstract] [Full Text] [Related]

  • 17. Current status of chemotherapy in gynecologic cancer.
    Tropé C, Kristensen G.
    Semin Oncol; 1997 Oct 14; 24(5 Suppl 15):S15-1-S15-22. PubMed ID: 9346216
    [No Abstract] [Full Text] [Related]

  • 18. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S, Yeap B, Vogl S, Carbone P.
    Cancer; 1996 Feb 15; 77(4):733-42. PubMed ID: 8616766
    [Abstract] [Full Text] [Related]

  • 19. [Immunologic aspects of ovarian tumors].
    Makarov OV, Khashchukoeva AZ, Borisenko SA, Epeĭkina TN, Moiseeva NB.
    Akush Ginekol (Mosk); 1988 Nov 15; (11):3-6. PubMed ID: 3071162
    [No Abstract] [Full Text] [Related]

  • 20. [T- and B-lymphocytes in bronchial cancer].
    Ruszel KB, Mierzejewska A.
    Wiad Lek; 1980 Jun 15; 33(12):951-5. PubMed ID: 6968482
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.